Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
NCT06506643
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
CLL
Solid Tumor, Adult
Interventions
DRUG:
Zinc-64 Aspartate
Sponsor
Vector Vitale LLC